Debarment and ExclusionspersonID: us-fdadq-1581e3ed15124d5f9145c58b3622a8c09807ace1
Albert J. Bazo
Primary Source
US FDA RESTRICTED
Coverage
us
Risk Tier
High
Last Updated
2026-07-26
Compliance Profile
"Risk Advisory: Records indicate that Albert J. Bazo is associated with US FDA RESTRICTED. Source-list verification is recommended."
Banking Impact
Records on US FDA RESTRICTED can trigger enhanced due diligence, compliance holds, counterparty review and documentation requests from banks, investors or procurement teams.
Legal Status
The record should be reviewed against the original source list, jurisdiction and date of publication before decisions are made. Escalation may be required for procurement, onboarding or investor diligence.
Official Source Metadata
Source: Debarment and Exclusions| Full Legal Name | Albert J. Bazo |
| Source Records | US FDA RESTRICTED |
| Enforcement Type | Debarment and Exclusions |
| Risk Topics | debarment |
Associated Subject Network
" Ključavničarstvo ",servisiranje in Montaža Miran Vertačnik S.p.
"Bruma" Vulkanizerstvo in Prodaja Avtoplaščev Matija Brunskole S.p.
"Centavria" Elektroinštalacije, Posredovanje in Organiziranje Kulturnih Dejavnosti, Posredovanje Pri Prodaji Blaško Goran S.p.
"Centralvod" Antun Đuran S.p.
Compliance Context Review
Independent Risk Assessment
SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for individuals seeking to clarify a public record or counterparty signal.
Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Confidential Review
Export PDFSubscriber Only